CCM
NNVC icon

Condor Capital Management’s NanoViricides NNVC Stock Holding History

Condor Capital Management’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-570
Closed -$13K – 169
2017
Q3 		$13K Hold
570
– – ﹤0.01% 175
2017
Q2 		$15K Buy
+570
New +$14.1K ﹤0.01% 176

Other funds holding NNVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PTB
Pioneer Trust Bank Salem, Oregon $441M AUM 21.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Raymond James & Associates
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
IHT Wealth Management
IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return

Condor Capital Management's NNVC Position: Q4 2017 in Review

Condor Capital Management sold out of NanoViricides (NNVC) in Q4 2017, closing a stake of 570 shares — an estimated $13K sold.

Condor Capital Management first reported a position in NNVC in Q2 2017 and held it in 2 quarters. The position peaked at $15K in Q2 2017. 44 funds tracked by Wall St. Rank hold NNVC as of Q4 2017.

  • Condor Capital Management reported no remaining NanoViricides position as of Q4 2017 after selling out during the quarter.
  • Condor Capital Management sold 570 NanoViricides shares in Q4 2017, an estimated $13K.
  • Condor Capital Management first reported a position in NanoViricides in Q2 2017 and held it in 2 quarters.
  • Condor Capital Management's NanoViricides position peaked at $15K in Q2 2017.
  • 44 funds tracked by Wall St. Rank held NanoViricides as of Q4 2017.

Based on Condor Capital Management's 13F filing for Q4 2017, filed 8 Feb 2018.